companydata.dkSYNACT PHARMA ApS: Financial statements 2025
CVR: 34459975
SYNACT PHARMA ApS (CVR 34459975) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -53,194,923 and a net result of DKK -59,812,937 compared with DKK -30,477,376 the year before. Equity amounted to DKK 20,295,649. The solvency ratio was 63.4%.
- Gross Profit
- -53,194,923 kr.
- Profit/Loss
- -59,812,937 kr.
- Equity
- 20,295,649 kr.
- Total Assets
- 32,003,914 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -53.2 mio. | -59.8 mio. | 20.3 mio. | 0 |
| 2024 | - | -26.3 mio. | -30.5 mio. | 25.1 mio. | 4 |
| 2023 | - | -63.4 mio. | -65.4 mio. | 15.6 mio. | 3 |
| 2022 | - | -47 mio. | -49.8 mio. | 34 mio. | 3 |
| 2021 | - | -43.4 mio. | -41.2 mio. | 6.6 mio. | 2 |
Find more companies like SYNACT PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
SYNACT PHARMA ApS has published its annual report for 2024. Gross profit came to DKK -26,274,866, and the net result was DKK -30,477,376.
About SYNACT PHARMA ApS
SYNACT PHARMA ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SYNACTION PHARMA ApS. The management consists of Jeppe Øvli Øvlesen, Thomas Boesen and Ann Kristin Brøgger Led. The company is owned by SynAct Pharma AB. In 2025, the company reported a gross profit of DKK -53,194,923 and a net result of DKK -59,812,937 compared with DKK -30,477,376 the year before. Equity amounted to DKK 20,295,649.